Renovaro Biosciences Inc. (RENB:NASDAQ) rocketted at $1.55, representing a gain of 82.4%. On Wed, Aug 09, 2023, RENB:NASDAQ touched a New 2-Week High of $1.55. The stock appeared on our News Catalysts scanner on Wed, Aug 09, 2023 at 09:47 AM in the 'AGREEMENT' category.
About Renovaro Biosciences Inc. (RENB:NASDAQ)
Enochian BioSciences Inc is a biopharmaceutical company. It is engaged in identifying, developing, manufacturing, and commercializing gene therapies.
Top 10 Gainers:
- Tango Therapeutics Inc. (TNGX:NASDAQ), 103.92%
- Renovaro Biosciences Inc. (RENB:NASDAQ), 82.35%
- Decibel Therapeutics Inc. (DBTX:NASDAQ), 80.29%
- Benitec Biopharma Inc. (BNTC:NASDAQ), 65.8%
- Science 37 Holdings Inc. (SNCE:NASDAQ), 53.24%
- Kubient Inc. (KBNT:NASDAQ), 44.37%
- Scopus BioPharma Inc. (SCPS:NASDAQ), 42.5%
- Poseida Therapeutics Inc. (PSTX:NASDAQ), 37.88%
- Esports Technologies Inc. (EBET:NASDAQ), 37.5%
- Planet Green Holdings Corp. (PLAG:NYSEMKT), 34.89%